The information you will find on this page provide you with a closer look into our progress on identifying, prioritizing, designing and facilitating the implementation of solutions that drive efficient, effective and high-quality delivery of new medicines.
This video explores our key patient focused initiatives aimed at increasing patient engagement and decreasing patient burden in clinical trials.
Overview of our Patient Subcommittee
During PCT Europe, Rob DiCicco, Vice President, Clinical Innovation and Digital Platforms at GSK, explains how end-to-end patient engagement is vital to patient-centricity in clinical trials.
Rob DiCicco, VP at GSK on Patient-Centricity in Clinical Trials
Want to learn more about TransCelerate? Check out our video to understand why we've joined together, what we've accomplished and what we have in store for the future.
This video discusses our work focused on facilitating information sharing and the harmonization of clinical trial processes.
Overview for our Information Sharing & Harmonization Subcommittee
This video explores one of our key areas of focus - improving the site investigator experience.
Overview of our Sites Subcommittee
See All Videos
The SIP is an innovative game-changer that revolutionizes communications between investigator sites & sponsors.
About our Shared Investigator Platform (SIP)
TransCelerate BioPharma Inc. is featured in PM360’s third annual Innovations in Pharma Marketing special issue as an innovative company in 2014. The article entitled “Innovators 2014: Companies” highlights how important innovation is to the success of the life science industry. The article provides a brief overview of TransCelerate and key accomplishments from the original five initiatives: Site Qualification & Training, Risk-Based Monitoring, Clinical Data Standards, Comparator Drug Network and Shared Investigator Platform.
LEARN MORE >
This Life Science Leader cover story is a comprehensive overview of TransCelerate Biopharma's founding and vision. The article is an interview with CEO Dalvir Gill, where he discusses the unmet needs TransCelerate is addressing, the power of collaboration among pharmaceutical companies, the organization’s different initiatives and how the key to overcoming skeptics lies in TransCelerate's ability to deliver results.
LEARN MORE >
This article reviews TransCelerate’s five key projects in its first year of operation. It also provides a discussion on its future initiatives. TransCelerate now has one of the most prized characteristics of successful organizations: the ability to deliver results on stated initiatives.
LEARN MORE >
You can search by Initiative or by Keyword
Follow Us on Twitter or Join Us on LinkedIn
Get updates from TransCelerate